Seattle, WA, United States of America

Maria M Dasovich

USPTO Granted Patents = 15 


 

Average Co-Inventor Count = 7.3

ph-index = 11

Forward Citations = 436(Granted Patents)


Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Maria M Dasovich: Innovator in Cytokine Receptor Technology

Introduction

Maria M Dasovich is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of cytokine receptors. With a total of 15 patents to her name, her work has advanced the understanding and application of cytokine antagonists.

Latest Patents

Among her latest patents are methods for producing a ZCYTOR17 heterodimeric cytokine receptor. These patents disclose novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods. The ZCYTOR17-containing multimeric or heterodimer cytokine receptors may be utilized as novel cytokine antagonists. Additionally, her inventions include methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid, and myeloid cells both in vitro and in vivo. The present inventions also encompass methods for producing the multimeric or heterodimeric cytokine receptor, along with their uses and associated antibodies.

Career Highlights

Maria M Dasovich is currently associated with Zymogenetics, Inc., where she continues to innovate in her field. Her extensive research and development efforts have positioned her as a leader in cytokine receptor technology.

Collaborations

Some of her notable coworkers include Cindy A Sprecher and Joseph Leon Kuijper, who have collaborated with her on various projects.

Conclusion

Maria M Dasovich's contributions to biotechnology, particularly in cytokine receptor technology, have been groundbreaking. Her innovative patents and ongoing work at Zymogenetics, Inc. continue to influence the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…